Compare Johnson & Johnson (JNJ) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs NIO Inc. — how do they compare? Johnson & Johnson trades at $261.43 (market cap $618.09B), while NIO Inc. trades at $3.58 (market cap $8.62B). The key difference: Johnson & Johnson is far larger — about 71.7× NIO Inc.'s market cap, and Johnson & Johnson pays a 2.09% dividend while NIO Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and NIO Inc. for 81 Days on average.
| JNJ | NIO | |
|---|---|---|
Market Cap | $618.09B | $8.62B |
Volume | 6,050,983 | 39,648,517 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $7.46 |
52-Week Low | $186.00 | $3.37 |
Typical Hold Time | 129 Days | 81 Days |
Enterprise Value | $646.37B | $6.52B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
NIO trades at $3.58, up 1.13% in the last session but near a 52-week low amid a bearish technical trend. The company reported Q3 2026 deliveries up 25.4% and recently formed a strategic battery-swap partnership with Geely, yet it continues to post net losses with a -4.17% net margin. Analyst consensus is a 'Buy' with a $6.23 price target, but high debt and negative cash flows pose challenges.
The outlook remains cautious; revenue growth and partnership potential offer upside, but persistent losses, cash burn, and intense EV competition present significant risks. Investors should weigh the long-term battery-swap network expansion against near-term financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
